You're viewing a public preview of Biotica Ltd. - Highly Potent, Novel Cyclophilin Inhibitors Sign up free to access full investment history, financials, executives & more
Sign Up Free Log In

Biotica Ltd. - Highly Potent, Novel Cyclophilin Inhibitors

Inactive
Cambridge,  CB21 6AD,  United Kingdom
Sector: Education Entity: Private
Merged Biotica Ltd. - Highly Potent, Novel Cyclophilin Inhibitors merged into NeuroVive Pharmaceutical AB in 2013
2
Transactions
Sign up to view
About Biotica Ltd. - Highly Potent, Novel Cyclophilin Inhibitors
Available information shows that Biotica Ltd. - Highly Potent, Novel Cyclophilin Inhibitors operates in the Education sector. The company has attracted investment from NeuroVive Pharmaceutical AB. The company is headquartered in Cambridge. Biotica Ltd. - Highly Potent, Novel Cyclophilin Inhibitors is profiled within Acquity Data.
Investors
Current Investors
NeuroVive Pharmaceutical AB ••••••••
Past Investors
•••••••• ••••••••
View Full Investor List
Sign up to see all current & past investors with deal dates and transaction details
Sign Up Free Log In
Investment Details
2 Transactions
Trans. IDInvestment DateExit DateInvestor(s)Deal Size (M)Seller(s)
Access 2 Transactions
Sign up to view the full investment history — dates, deal sizes, investors & sellers
Sign Up Free Log In
Biotica Ltd. - Highly Potent, Novel Cyclophilin Inhibitors M&A Activity
# Company Transaction Date Close Date Sector Country
View M&A Acquisitions
Sign up to explore the full acquisition & merger history
Sign Up Free Log In
Key Executives & Professionals
View Executives & Professionals
Sign up to access board members, senior management & key contacts
Sign Up Free Log In
Frequently Asked Questions
What does Biotica Ltd. - Highly Potent, Novel Cyclophilin Inhibitors do?
Available information shows that Biotica Ltd. - Highly Potent, Novel Cyclophilin Inhibitors operates in the Education sector. The company has attracted investment from NeuroVive Pharmaceutical AB. The company is headquartered in Cambridge. Biotica Ltd. - Highly Potent, Novel Cyclophilin Inhibitors i
Where is Biotica Ltd. - Highly Potent, Novel Cyclophilin Inhibitors headquartered?
Biotica Ltd. - Highly Potent, Novel Cyclophilin Inhibitors is headquartered in Cambridge, United Kingdom.
When was Biotica Ltd. - Highly Potent, Novel Cyclophilin Inhibitors founded?
Founded year information for Biotica Ltd. - Highly Potent, Novel Cyclophilin Inhibitors is available on AcquityData.
What sector is Biotica Ltd. - Highly Potent, Novel Cyclophilin Inhibitors in?
Biotica Ltd. - Highly Potent, Novel Cyclophilin Inhibitors operates in the Education sector.
Who are the investors in Biotica Ltd. - Highly Potent, Novel Cyclophilin Inhibitors?
Current investors in Biotica Ltd. - Highly Potent, Novel Cyclophilin Inhibitors include NeuroVive Pharmaceutical AB. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has Biotica Ltd. - Highly Potent, Novel Cyclophilin Inhibitors been involved in?
Biotica Ltd. - Highly Potent, Novel Cyclophilin Inhibitors has 2 transactions tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.

Unlock the full Biotica Ltd. - Highly Potent, Novel Cyclophilin Inhibitors profile

Ownership & Investors M&A History Financials Key Executives Advisors & Lenders

Access Biotica Ltd. - Highly Potent, Novel Cyclophilin Inhibitors's complete ownership history, M&A activity, investors, advisors and executives in one connected platform.

Start Free Trial